Arti­kel

Aktu­el­le Artikel

Böhm S, Wou­den­berg T, Stark K, Böh­mer MM, Katz K, Kuh­nert R, Schlaud M, Fin­ger­le V, Wil­king H. Sero­pr­e­va­lence, ser­o­con­ver­si­on and sero­re­ver­si­on of Bor­re­lia burg­dor­fe­ri-spe­ci­fic IgG anti­bo­dies using two popu­la­ti­on-based stu­dies in child­ren and ado­le­s­cents in Ger­ma­ny (KiGGS), 2003–2006 and 2014–2017. Euro­sur­veil­lan­ce 2023 (in press).

Offer­geld R, Preu­ßel K, Zei­ler T, Aurich K, Bau­mann-Baret­ti BI, Cie­sek S, Cor­man VM, Dienst V, Dros­ten C, Görg S, Greinacher A, Gros­se­ges­se M, Hal­ler S, Heuft HG, Hof­mann N, Horn PA, Hou­areau C, Güleç I, Jimé­nez Kling­berg CL, Juhl D, Lin­de­mann M, Mar­tin S, Neu­hau­ser HK, Nit­sche A, Ohme J, Pei­ne S, Sachs UJ, Schaa­de L, Schä­fer R, Schei­blau­er H, Schlaud M, Schmidt M, Umhau M, Voll­mer T, Wag­ner FF, Wie­ler LH, Wil­king H, Zie­mann M, Zim­mer­mann M, an der Hei­den MA. Moni­to­ring the SARS-CoV‑2 pan­de­mic: pre­va­lence of anti­bo­dies in a lar­ge, repe­ti­ti­ve cross-sec­tion­al stu­dy of blood donors in Ger­ma­ny – results from the SeBlu­Co stu­dy 2020–2022. Patho­gens 2023; 12 (4): 551. doi:10.3390/pathogens12040551

---

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992